...
首页> 外文期刊>International Hatchery Practice >Smaller hatcheries are now reaping the benefits of in ovo technology
【24h】

Smaller hatcheries are now reaping the benefits of in ovo technology

机译:小型孵化场现在正从卵技术中受益

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The introduction of the first commercial in ovo vaccination system over 20 years ago was one of the driving forces behind the increasing size and efficiency of hatcheries that we have witnessed over the intervening years. Globally, more than 15 billion eggs are now vaccinated each year using in ovo devices, and the technology has allowed companies to improve the performance of their birds. Until recently, in ovo technology was generally considered as a tool for larger companies with a throughput thatjustified the investment both financially and in terms of space. In fact, it may have even contributed to the creation of a two-tier hatchery industry in developed markets. However, last year Zoetis, the same company that brought us the first commercialsystem, launched a new, smaller in ovo device designed specifically with smaller hatcheries in mind.
机译:在过去的20年中,我们见证了孵化场规模和效率不断提高的背后推动力量之一,这是20多年前引入的第一个商业化卵疫苗接种系统。在全球范围内,现在每年有超过150亿个卵用卵内设备进行疫苗接种,这项技术使公司能够提高禽类的性能。直到最近,卵内技术一直被认为是大公司的一种工具,其吞吐率可以在财务和空间方面使投资合理化。实际上,它甚至可能有助于在发达市场建立两级孵化场产业。但是,去年Zoetis,为我们带来了第一个商业系统的公司,推出了一种新的,较小的卵内设备,该设备专门为较小的孵化场而设计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号